Prosecution Insights
Last updated: November 04, 2026
Application No. 18/577,751

CONFORMAL CONTRACEPTION DEVICES AND METHODS

Non-Final OA §102§103§112
Filed
Jan 09, 2024
Priority
Jul 16, 2021 — provisional 63/222,932 +2 more
Examiner
NELSON, KERI JESSICA
Art Unit
3786
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Venova Technologies Inc.
OA Round
3 (Non-Final)
59%
Grant Probability
Moderate
3-4
OA Rounds
4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
575 granted / 981 resolved
-11.4% vs TC avg
Strong +41% interview lift
Without
With
+41.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
21 currently pending
Career history
1016
Total Applications
across all art units

Statute-Specific Performance

§101
4.1%
-35.9% vs TC avg
§103
44.6%
+4.6% vs TC avg
§102
18.1%
-21.9% vs TC avg
§112
27.9%
-12.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 981 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION This Office action is based on the amendments filed September 10, 2026 with a request for continued examination of application 18/577,751. Claims 1 and 26 have been amended, claims 8 and 10-13 have been cancelled, and claims 91 and 92 are newly presented; claims 1-5, 19, 24-26, 48-50, 52, 91, and 92 are currently pending. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant’s submission filed on September 10, 2026 has been entered. Response to Arguments Applicant’s arguments filed September 10, 2026 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. In response to Applicant’s argument that the device that Nakamura describes a silicone rubber sleeve wrapped around a stem such that the sleeve is composed of silicon rubber than the device itself, it is noted that claims 1 and 26 each recite that the housing is made from silicone or a silicone-based elastomer but does not limit the housing to be made only from silicone or a silicone-based elastomer. Similarly, Rudakov (US 2012/0192872), which is now relied upon as the primary reference in the rejection of claims 1 and 26, discloses an analogous housing made from the elongate member (12) in combination with the flow reducing member (14), wherein at least the flow reducing member (14) of the housing is made from silicone (¶ 0213). Further, Rudakov discloses that the housing (12+14) is configured to expand from a radially compressed configuration to engage and seal against an inner surface of a lumen to obstruct flow of fluid flowing through the lumen (¶ 0128-0129 & 0224), wherein the housing (12+14) must therefore have a conformal outer surface in order to achieve a sufficient seal with the inner surface of the lumen to obstruct the flow of fluid. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 91 and 92 are rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 91 and 92, each recite the limitation “The method of claim 1”; however, there is insufficient antecedent basis for “The method” since claim 1 is directed to a “device” rather than a “method”. For examination purposes, the above limitation of claims 91 and 92 has been interpreted as “The device of claim 1”. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-5, 19, 26, and 48 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Rudakov et al. (US 2012/0192872). Regarding claim 1, Rudakov discloses an intracervical conformal contraceptive device (apparatus 10 may be used to reduce or stop flow through a tubular structure including a cervical canal) (¶ 0144) comprising a housing (elongate member 12 + flow reducing member 14) made from silicone or a silicone-based elastomer and having an outer surface (flow reducing member 14), the housing (12+14) defining a conduit passing from a first proximal end (proximal opening 18) to a second distal end (distal opening 16) of the housing (12+14), wherein the housing (12+14) comprises a one-way valve (flap 78) within the conduit, the one-way valve (78) allowing fluid to pass from the first proximal end (18) to the second distal end (16) (Figs. 1-2 & 18; ¶ 0013, 0128, 0136, & 0213). Rudakov further discloses that the housing (12+14) is configured to expand from a radially compressed configuration to engage and seal against an inner surface of a lumen to obstruct flow of fluid flowing through the lumen (¶ 0128-0129 & 0224) thereby rendering the outer surface of the housing to be conformal to the shape of the lumen. Regarding claim 2, Rudakov further discloses that the housing (12+14) is substantially tubular (Fig. 1). Regarding claim 3, Rudakov further discloses that the housing (12+14) is substantially spindle-shaped (Fig. 2). Regarding claim 4, Rudakov further discloses that the device (10) has a length of no more than 3 cm (¶ 0141). Regarding claim 5, Rudakov further discloses that the device (10) has a diameter of no more than 12 mm (¶ 0142). Regarding claim 19, Rudakov further discloses a spermicidal agent position in the housing (12+14) (¶ 0198). Regarding claim 26, Rudakov discloses a method comprising inserting a device (apparatus 10) into a cervix of a subject (apparatus 10 may be used to reduce or stop flow through a tubular structure including a cervical canal) (¶ 0144), the device (10) comprising a housing (elongate member 12 + flow reducing member 14) made from silicone or a silicone-based elastomer and having an outer surface (flow reducing member 14), the housing (12+14) defining a conduit passing from a first end (proximal opening 18) to a second end (distal opening 16) of the housing (12+14), wherein the housing (12+14) comprises a one-way valve (flap 78) within the conduit such that the one-way valve (78) is positioned to allow fluid to exit a vagina (flap 78 facilitations proximal flow through the distal opening) (Figs. 1-2 & 18; ¶ 0013, 0128, 0136, & 0213). Rudakov further discloses that the housing (12+14) is configured to expand from a radially compressed configuration to engage and seal against an inner surface of a lumen to obstruct flow of fluid flowing through the lumen (¶ 0128-0129 & 0224) thereby rendering the outer surface of the housing to be conformal to the shape of the lumen. Regarding claim 48, Rudakov further discloses that the housing (12+14) comprises a retention mechanism (coated with agents suitable for facilitating engagement of frame 76 to an inner surface of a lumen) (¶ 0134). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 24 is rejected under 35 U.S.C. 103 as being unpatentable over Rudakov as applied to claim 1 above, in view of Nakamura et al. (US 4,004,582). Rudakov discloses the invention substantially as claimed, as described above, but fails to teach that the housing comprises a flange at the first proximal end of the device. Nakamura discloses an analogous intracervical conformal contraceptive device (intracervical contraceptive device ICD 10) comprising a housing (stem 12 + sleeve 34) having a conformal outer surface (sleeve 34) and defining a conduit (hollow bore 14) passing from a first proximal end (inner end 16) to a second distal end (outer end 22) of the housing (12+34), wherein the housing (12+34) comprises a flange (arms 18+20) at the first proximal end (16) of the device (10) (Figs. 1-2 & 4; column 2, lines 35-43; column 3, lines 1-4, 8-17, & 28-39). Therefore, it would have been obvious to one having ordinary skill in the art, before the effective filing date of the invention, to modify the housing of the intracervical conformal contraceptive device taught by Rudakov to comprise a flange at the first proximal end of the device as taught by Nakamura for the purpose of preventing inadvertent expulsion of the device. Claim 25 is rejected under 35 U.S.C. 103 as being unpatentable over Rudakov as applied to claim 1 above, in view of Silber (US 3,312,215). Rudakov discloses the invention substantially as claimed, as described above, but fails to teach that the housing comprises a flange at the second distal end of the device. Silber discloses an analogous intracervical device (uterocervical cannula) comprising a housing (stem S + collar member C) defining a conduit from a first proximal end (portions 13a+13b) to a second distal end (portions 18a+18b), wherein the housing (S+C) comprises a flange (collar member C) at the second distal end (18a+18b) of the device (Figs. 2, 7, & 26; column 6, lines 20-39). Therefore, it would have been obvious to one having ordinary skill in the art, before the effective filing date of the invention, to modify the housing of the intracervical conformal contraceptive device taught by Rudakov to comprises a flange at the second distal end of the device as taught by Silber for the purpose of preventing movement of the device towards the uterus. Claim 49 is rejected under 35 U.S.C. 103 as being unpatentable over Rudakov as applied to claims 26 and 48 above, in view of Waterbury (US 2,422,377). Rudakov discloses the method substantially as claimed, as described above, but fails to teach that the retention mechanism comprises one or more circumferential vanes. Waterbury discloses an analogous method comprising inserting a device (pessary) into a cervix of a subject, the device comprising a housing (stem 11) having a retention mechanism, wherein the retention mechanism comprises one or more circumferential vanes (disks 26) (Figs. 1-2; column 2, lines 18-23; column 3, lines 56-75; column 4, lines 1-12). Therefore, it would have been obvious to one having ordinary skill in the art, before the effective filing date of the invention, to modify the housing of the device used in the method taught by Rudakov such that the retention mechanism comprises one or more circumferential vanes as taught by Waterbury for the purpose of assisting in retaining the device in proper position and also serving to prevent the entrance of foreign substances into the cavity of the uterus. Claims 50 and 52 are rejected under 35 U.S.C. 103 as being unpatentable over Rudakov as applied to claims 1 and 48 above, in view of Ragheb (US 10,159,597). Rudakov discloses the method substantially as claimed, as described above, but fails to teach that the retention mechanism comprises one or more ridges or that the housing has a textured surface. Ragheb discloses an analogous method comprising inserting a device (birth control assembly 10) into a cervix of a subject, the device (10) comprising a housing (tube 12) having a retention mechanism, wherein the retention mechanism comprises one or more ridges (rings 22) which provide the housing with a textured surface (Figs. 1 & 5; column 2, lines 21-27). Therefore, it would have been obvious to one having ordinary skill in the art, before the effective filing date of the invention, to modify the housing of the device used in the method taught by Rudakov such that the retention mechanism comprises one or more ridges thus providing the housing with a textured surface as taught by Ragheb for the purpose of frictionally engage the cervix to facilitate retaining the housing in the cervix. Claims 91 and 92 are rejected under 35 U.S.C. 103 as being unpatentable over Rudakov as applied to claim 1 above, in view of DeLaurentis et al. (US 5,295,979). Rudakov discloses the invention substantially as claimed, as described above, but fails to teach that the one-way valve comprises a rigid material that prevents distortion of the one-way valve and a plurality of flaps. DeLaurentis discloses an analogous one-way valve (one-way valve 500/600) configured to allow fluid to pass from a first end (input portion 510/610) to a second end (output port 512/612), wherein the one-way valve (500/600) comprises a rigid material (more rigid flap portion 618) capable of preventing distortion of the one-way valve (500/600) and a plurality of flaps (flaps 516/616) (Figs. 5a-6; column 7, line 51 – column 8, line 23). Therefore, it would have been obvious to one having ordinary skill in the art, before the effective filing date of the invention, to modify the one-way valve of the device taught by Rudakov to comprise a rigid material and a plurality of flaps as taught by DeLaurentis for the purpose of providing added resistance to reflux pressure. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Keri J. Nelson whose telephone number is 571-270-3821. The examiner can normally be reached Monday - Friday, 9am - 4pm. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Rachael E. Bredefeld, can be reached at 571-270-5237. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KERI J NELSON/Primary Examiner, Art Unit 3786 10/28/2026
Read full office action

Prosecution Timeline

Jan 09, 2024
Application Filed
Aug 19, 2025
Non-Final Rejection mailed — §102, §103, §112
Feb 18, 2026
Response Filed
Mar 13, 2026
Final Rejection mailed — §102, §103, §112
Sep 10, 2026
Request for Continued Examination
Sep 14, 2026
Response after Non-Final Action
Oct 29, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773338
SCOLIOSIS BRACE WITH INFLATABLE PRESSURE BLADDERS AND SCOLIOSIS TREATMENT METHODS USING THE SAME
2y 12m to grant Granted Oct 27, 2026
Patent 12746142
ORTHOPAEDIC DEVICE
3y 6m to grant Granted Sep 29, 2026
Patent 12746138
Knee Cushion Apparatus
3y 8m to grant Granted Sep 29, 2026
Patent 12740906
PERSON SUPPORT APPARATUSES INCLUDING INTUBATION ASSISTANCE DEVICES AND METHODS OF USING THE SAME
1y 10m to grant Granted Sep 22, 2026
Patent 12740885
STERNUM STABILIZATION VEST
1y 8m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
59%
Grant Probability
99%
With Interview (+41.1%)
3y 2m (~4m remaining)
Median Time to Grant
High
PTA Risk
Based on 981 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month